Total Payments
$96,799
2024 Payments
$49.65
Companies
52
Transactions
858
Medicare Patients
5,121
Medicare Billing
$402,523
Payment Breakdown by Category
Other$70,435 (72.8%)
Food & Beverage$14,366 (14.8%)
Consulting$7,818 (8.1%)
Travel$3,738 (3.9%)
Education$442.01 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,435 | 29 | 72.8% |
| Food and Beverage | $14,366 | 791 | 14.8% |
| Consulting Fee | $7,818 | 3 | 8.1% |
| Travel and Lodging | $3,738 | 22 | 3.9% |
| Education | $442.01 | 13 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $54,648 | 223 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18,345 | 97 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $14,258 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,519 | 83 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $750.54 | 59 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $637.11 | 35 | $0 (2023) |
| Harmony Biosciences LLC | $620.25 | 29 | $0 (2023) |
| United Therapeutics Corporation | $579.12 | 21 | $0 (2022) |
| Grifols USA, LLC | $525.42 | 32 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $512.15 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.65 | 1 | Inspire Medical Systems, Inc. ($49.65) |
| 2023 | $1,323 | 63 | GlaxoSmithKline, LLC. ($354.50) |
| 2022 | $37,427 | 157 | GlaxoSmithKline, LLC. ($35,274) |
| 2021 | $10,576 | 116 | GlaxoSmithKline, LLC. ($9,032) |
| 2020 | $2,078 | 123 | GlaxoSmithKline, LLC. ($309.98) |
| 2019 | $7,613 | 131 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,888) |
| 2018 | $13,640 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,290) |
| 2017 | $24,092 | 162 | Janssen Pharmaceuticals, Inc ($13,486) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $49.65 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Respiratory | ||||||
| 12/05/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 10/17/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Airway Clearance Device | ||||||
| 10/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: NEUROLOGY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $22.51 | General |
| 08/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Respiratory | ||||||
| 08/09/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 460 | 564 | $147,304 | $37,135 |
| 2022 | 13 | 1,507 | 2,025 | $178,587 | $128,283 |
| 2021 | 11 | 1,551 | 1,926 | $168,340 | $117,926 |
| 2020 | 10 | 1,603 | 2,015 | $174,087 | $119,178 |
Total Patients
5,121
Total Services
6,530
Medicare Billing
$402,523
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 237 | $91,632 | $23,089 | 25.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 81 | 89 | $15,218 | $3,858 | 25.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 73 | 78 | $10,268 | $2,593 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,557 | $2,525 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 38 | $10,383 | $2,523 | 24.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 59 | 63 | $5,362 | $1,311 | 24.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 34 | 40 | $4,884 | $1,236 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 381 | 668 | $87,482 | $62,964 | 72.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 256 | 321 | $20,090 | $14,839 | 73.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 106 | 106 | $18,486 | $12,067 | 65.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 222 | 274 | $13,019 | $9,017 | 69.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 32 | 32 | $8,472 | $8,246 | 97.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 224 | 290 | $8,626 | $5,861 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 87 | $8,161 | $5,460 | 66.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 23 | $4,267 | $2,883 | 67.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 79 | 97 | $4,573 | $2,788 | 61.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 41 | 45 | $2,531 | $1,941 | 76.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 32 | 32 | $960.00 | $949.50 | 98.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 28 | 32 | $1,254 | $832.66 | 66.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 16 | 18 | $666.19 | $434.68 | 65.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 376 | 607 | $80,571 | $56,864 | 70.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 271 | 315 | $20,296 | $15,085 | 74.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 104 | 104 | $18,244 | $12,562 | 68.9% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 246 | 288 | $13,905 | $9,646 | 69.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 111 | $10,352 | $7,030 | 67.9% |
About Dr. Thomas Demarini, MD
Dr. Thomas Demarini, MD is a Pulmonary Disease healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407831696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Demarini, MD has received a total of $96,799 in payments from pharmaceutical and medical device companies, with $49.65 received in 2024. These payments were reported across 858 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,435).
As a Medicare-enrolled provider, Demarini has provided services to 5,121 Medicare beneficiaries, totaling 6,530 services with total Medicare billing of $402,523. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Decatur, GA
- Active Since 12/09/2005
- Last Updated 01/25/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1407831696
Products in Payments
- TRELEGY ELLIPTA (Drug) $30,965
- XARELTO (Drug) $14,233
- STIOLTO RESPIMAT (Drug) $567.31
- OFEV (Drug) $564.04
- Wakix (Drug) $538.79
- ORENITRAM (Drug) $506.11
- LONHALA MAGNAIR (Drug) $460.06
- DUPIXENT (Biological) $419.47
- SYMBICORT (Drug) $381.97
- ACTHAR (Biological) $377.90
- BREZTRI (Drug) $357.46
- NUCALA (Biological) $350.55
- Yupelri (Drug) $326.62
- INJECTAFER (Drug) $307.56
- Arikayce (Drug) $306.05
- UPTRAVI (Drug) $302.09
- ANORO (Drug) $300.66
- GLASSIA (Biological) $291.44
- Prolastin-C Liquid (Biological) $278.50
- TEZSPIRE (Biological) $275.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Decatur
David Miller, M.d, M.D
Pulmonary Disease — Payments: $225,340
Pulmonary Disease $225,340
Jose Aristizabal, Md, MD
Pulmonary Disease — Payments: $18,695
Pulmonary Disease $18,695
Dr. Harold Jackson, Md, MD
Pulmonary Disease — Payments: $15,093
Pulmonary Disease $15,093
Terri Tenhoor, Md, MD
Pulmonary Disease — Payments: $8,956
Pulmonary Disease $8,956
Danxuan Long, Md, MD
Pulmonary Disease — Payments: $4,238
Pulmonary Disease $4,238
Thomandram Sekar, Md, MD
Pulmonary Disease — Payments: $4,005
Pulmonary Disease $4,005